Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

Peter Illes, Christa E. Müller, Kenneth A. Jacobson, Thomas Grutter, Annette Nicke, Samuel J. Fountain, Charles Kennedy, Günther Schmalzing, Michael F. Jarvis, Stanko S. Stojilkovic, Brian F. King, Francesco Di Virgilio

Research output: Contribution to journalReview articlepeer-review

163 Citations (Scopus)
10 Downloads (Pure)


The known seven mammalian receptor subunits (P2X1–7) form cationic channels gated by ATP. Three subunits compose a receptor channel. Each subunit is a polypeptide consisting of two transmembrane regions (TM1 and TM2), intracellular N- and C-termini, and a bulky extracellular loop. Crystallization allowed the identification of the 3D structure and gating cycle of P2X receptors. The agonist-binding pocket is located at the intersection of two neighbouring subunits. In addition to the mammalian P2X receptors, their primitive ligand-gated counterparts with little structural similarity have also been cloned. Selective agonists for P2X receptor subtypes are not available, but medicinal chemistry supplied a range of subtype-selective antagonists, as well as positive and negative allosteric modulators. Knockout mice and selective antagonists helped to identify pathological functions due to defective P2X receptors, such as male infertility (P2X1), hearing loss (P2X2), pain/cough (P2X3), neuropathic pain (P2X4), inflammatory bone loss (P2X5), and faulty immune reactions (P2X7).

Original languageEnglish
Pages (from-to)489-514
Number of pages26
JournalBritish Journal of Pharmacology
Issue number3
Early online date30 Oct 2020
Publication statusPublished - Feb 2021


  • (patho)physiological functions
  • P2X receptors
  • agonists
  • antagonists
  • extracellular ATP
  • knockout mice
  • ligand-gated cationic channels

Cite this